<DOC>
	<DOCNO>NCT02361515</DOCNO>
	<brief_summary>The present randomized , open , multicentric Phase II trial , parallel group two arm treatment , compare treatment A , moderate hypofractionated radiotherapy 62Gy , treatment B , stereotactic irradiation 37.5 Gy hyaluronic acid injection space prostate rectum preserve rectal-wall high dos irradiation . The study aim assess rate late urinary toxicity grade â‰¥ 2 induced moderate hypofractionated radiotherapy ( 62Gy 20 fraction 3.1Gy ) stereotactic radiotherapy ( 37.5Gy 5 fraction 7.5Gy ) , rectal toxicity injection hyaluronic acid rectal wall prostate . Ninety-six patient 9 center include protocol .</brief_summary>
	<brief_title>Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>age superior equal 18 year inferior 80 year . patient low intermediaterisk prostate cancer , accord D'Amico classification , exclusive irradiation . prostate cancer histologically proven . performance index OMS ( World Health Organization ) grade 02. indication external beam radiotherapy validate medical commission institution . IPSS ( International Prostate Symptom Score &lt; 15/35 ( without alphablocker ) . sign consent form . Rectal surgery antecedent . prostate resection less 6 mois . Involvement seminal vesicle capsule MRI . patient ca n't cooperate treatment . pelvic irradiation antecedent . antecedent inflammatory intestinal pathology . neoplasia . patient treat antineoplastic antiangiogenic treatment use rheumatology may include methotrexate ( order radiosensitizing effect ) . patient receive anticoagulant treatment . undergo study may interfere present study . patient legal protection measure . hypersensitivity hyaluronic acid . patient autoimmune disease . patient receive immunosuppressive medication . severe allergy . history endocarditis .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Prostate</keyword>
	<keyword>Hypofractionated radiotherapy</keyword>
	<keyword>Stereotactic irradiation</keyword>
	<keyword>Spacer</keyword>
	<keyword>Rectal bladder toxicity</keyword>
</DOC>